Concurrent Session 7C: Low Dead-Space Needle and Syringe Scale-Up and Peer-Led Harm Reduction: Building Prevention Synergies in Low- and Middle-Income Countries
Tracks
Track 3
| Friday, October 9, 2026 |
| 2:00 PM - 3:30 PM |
| Tycho + Kepler |
Details
Global hepatitis C elimination strategies emphasise the need for community-centred and peer-led approaches to implementation. Yet, research on innovative harm reduction technologies and service designs for people who inject drugs often focus on whether they are ‘effective’, rather than how they are made to work in practice, and how they may be adapted to enhance their potential.
This session is grounded in implementation experiences from community-led, multi-country research to increase the uptake and use of low dead-space needles and syringes (LDSS) in low- and middle-income countries. The critical role of community-led research and peer-led knowledge mobilisation in supporting implementation and uptake of new harm reduction technologies in diverse contexts will be explored.
Audience members will be invited to reflect on country case studies, implementation tools, and broader perspectives from a diverse panel of experts and implementer and consider the implications for designing and implementing meaningful, community-responsive approaches that take advantage of prevention innovations across LMIC settings and beyond.
Speaker
Dr Annie Madden
Project Lead
International Network of People Who Use Drugs (INPUD)
Welcome
2:00 PM - 2:02 PMBiography
Mr Mat Southwell
Managing And Technical Director
Coact Technical Support LTD
Welcome
2:00 PM - 2:02 PMBiography
Mat Southwell is Managing and Technical Director of Coact Technical Support. Coact is a community-led training and consultancy company that supports harm reduction, drug treatment, and community mobilisation with people who use drugs in international development settings. Mat has supported client literacy and choice in Unitaid study.
Dr Sophia Schroeder
Senior Research Officer
Burnet Institute
Enhancing the harm reduction potential of low-deadspace injecting equipment research in low- and middle-income countries
2:02 PM - 2:10 PMBiography
Mrs Fauziyya Abubakar
Program Officer
DAPHO
Community-led values and preferences research for expanding uptake and use of LDSS: Nigeria
2:10 PM - 2:18 PMBiography
Angela McBride
Executive Director
SANPUD
Community-led values and preferences research for expanding uptake and use of LDSS: South Africa
2:18 PM - 2:26 PMBiography
Mr Petik Yedigaryan
Autich
Real World Real People
Community-led values and preferences research for expanding uptake and use of LDSS: Armenia
2:26 PM - 2:35 PMBiography
INHSU 2026
Cross-cutting lessons and responses
2:35 PM - 2:45 PMBiography
Dr Karin Hatzold
Global Infectious Diseases Lead
PSI
Panel Discussion
2:45 PM - 3:25 PMBiography
Dr Karin Hatzold, MD, MPH, is a public health physician and PSI’s Global Infectious Diseases Lead, based in Cape Town, South Africa. She has more than 25 years of experience leading the development, evaluation and scale-up of innovations in infectious disease diagnostics, prevention and treatment across sub-Saharan Africa. Dr Hatzold is currently the Principal Investigator for Unitaid-funded implementation research evaluating the acceptability, feasibility and effectiveness of low-dead-space syringes (LDSS) and long-acting depot buprenorphine (LADB) within harm reduction programmes in South Africa and Nigeria. This work focuses on generating evidence to inform differentiated, person-centred approaches to opioid dependence treatment and HIV and viral hepatitis prevention and care. She previously led the STAR Initiative, one of the largest global programmes advancing HIV self-testing, and subsequently expanded this work to hepatitis C and COVID-19 self-testing. Evidence generated through these programmes contributed to WHO normative guidance and the adoption and scale-up of self-testing policies and programmes in more than 150 countries. In her current global role, Dr Hatzold also leads work on the introduction and scale-up of long-acting HIV prevention, integrated point-of-care diagnostics, differentiated service delivery, and digital and AI-enabled approaches across Africa. Her work focuses on translating research and technological innovation into policy, sustainable delivery models and large-scale public health impact.
Prof Magdalena Harris
Professor Of Inclusion Health Sociology
London School Of Hygiene & Tropical Medicine
Panel Discussion
2:45 PM - 3:25 PMBiography
Angela McBride
Executive Director
SANPUD
Panel Discussion
2:45 PM - 3:25 PMBiography
Mr Andrew Preston
Founder/Managing director
Exchange Supplies
Panel Discussion
2:45 PM - 3:25 PMBiography
Dr Sophia Schroeder
Senior Research Officer
Burnet Institute
Panel Discussion
2:45 PM - 3:25 PMBiography
Mr Petik Yedigaryan
Autich
Real World Real People
Panel Discussion
2:45 PM - 3:25 PMBiography
Dr Annie Madden
Project Lead
International Network of People Who Use Drugs (INPUD)
Where to from here?
3:25 PM - 3:30 PMBiography
Mr Mat Southwell
Managing And Technical Director
Coact Technical Support LTD
Where to from here?
3:25 PM - 3:30 PMBiography
Mat Southwell is Managing and Technical Director of Coact Technical Support. Coact is a community-led training and consultancy company that supports harm reduction, drug treatment, and community mobilisation with people who use drugs in international development settings. Mat has supported client literacy and choice in Unitaid study.
Chairperson
Annie Madden
Project Lead
International Network of People Who Use Drugs (INPUD)
Mat Southwell
Managing And Technical Director
Coact Technical Support LTD